| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| AZD1480; AZD1480 | CFN60233 | 935666-88-9 | C14H14ClFN8 = 348.77 | 5mg | QQ客服：2159513211 |
| Fedratinib (TG101348); Fedratinib (TG101348) | CFN60234 | 936091-26-8 | C27H36N6O3S = 524.68 | 5mg | QQ客服：215959384 |
| OSI-027; OSI-027 | CFN60235 | 936890-98-1 | C21H22N6O3 = 406.44 | 5mg | QQ客服：1457312923 |
| GSK690693; GSK690693 | CFN60236 | 937174-76-0 | C21H27N7O3 = 425.48 | 5mg | QQ客服：215959384 |
| KU-0063794; KU-0063794 | CFN60237 | 938440-64-3 | C25H31N5O4 = 465.54 | 5mg | QQ客服：2056216494 |
| 帕纳替尼; Ponatinib (AP24534) | CFN60238 | 943319-70-8 | C29H27F3N6O = 532.56 | 5mg | QQ客服：1413575084 |
| JNJ-38877605; JNJ-38877605 | CFN60239 | 943540-75-8 | C19H13F2N7 = 377.35 | 5mg | QQ客服：215959384 |
| 吉西他滨; Gemcitabine | CFN60240 | 95058-81-4 | C9H11F2N3O4 = 263.2 | 5mg | QQ客服：2159513211 |
| 奎扎替尼; Quizartinib (AC220) | CFN60241 | 950769-58-1 | C29H32N6O4S = 560.67 | 5mg | QQ客服：2159513211 |
| Sonidegib (NVP-LDE225); Sonidegib (NVP-LDE225) | CFN60242 | 956697-53-3 | C26H26F3N3O3 = 485.5 | 5mg | QQ客服：2159513211 |
| BMS-754807; BMS-754807 | CFN60243 | 1001350-96-4 | C23H24FN9O = 461.49 | 5mg | QQ客服：2056216494 |
| BV-6; BV-6 | CFN60244 | 1001600-56-1 | C70H96N10O8.xCF3COOH = 1205.57 | 5mg | QQ客服：2056216494 |
| MK-5108 (VX-689); MK-5108 (VX-689) | CFN60245 | 1010085-13-8 | C22H21ClFN3O3S = 461.94 | 5mg | QQ客服：1413575084 |
| CUDC-101; CUDC-101 | CFN60246 | 1012054-59-9 | C24H26N4O4 = 434.49 | 5mg | QQ客服：2159513211 |
| SGX-523; SGX-523 | CFN60247 | 1022150-57-7 | C18H13N7S = 359.41 | 5mg | QQ客服：3257982914 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)